Although China has established the basic drug centralized bid procurement system at the provincial level, the resulting drug prices are still unreasonable, therefore, the medical burden is too heavy. In this case, the second bar- gaining of drugs is put forward in some pilot provinces. However, it results in great controversy, which is thought not to be the effective measures to solve the problem of excessively rapid growth of medical expenses. To control the growth, the key is to improve the system of basic drug centralized bidding as well as ...
